Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Antisense transcript to CLCN4
- Molecular classification
- Non-coding RNA, Natural antisense transcript, Long non-coding RNA
01
Overview
The **antisense transcript to CLCN4** (ENSG00000299048) is a non-coding RNA transcribed from the DNA strand opposite to the CLCN4 gene locus on the X chromosome. Such transcripts, known as natural antisense transcripts, often function by regulating the chromatin state, transcriptional activity, or stability of their corresponding sense (protein-coding) transcripts. While antisense RNAs can influence gene expression in a variety of ways—including modifications to chromatin, mRNA stability, and transcriptional interference—the specific biological function and disease relevance of the antisense transcript to CLCN4 have not been experimentally established. There are no drugs or therapeutics that specifically target this transcript, nor is it used as a clinical biomarker. Its entry in gene databases reflects genomics annotations rather than established biological or therapeutic role[3][4].
- Other names
- ENSG00000299048CLCN4-AS
02
Biological functions
Chromatin modificationTranscriptional interferenceRNA stability regulationFine-tuning sense gene expression
03
Disease associations
There is no direct evidence that this specific antisense transcript is involved in a particular disease, but dysregulation of antisense transcripts can contribute to gene expression abnormalities, which have been implicated in various conditions in other contexts. The CLCN4 gene itself is linked to neurodevelopmental conditions, but the role of its antisense transcript in disease is not established.
Beyond the preview
Go deeper on Antisense transcript to CLCN4.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Antisense transcript to CLCN4.